Indivior PLC [INDV] vs Elanco Animal Health [ELAN] Detailed Stock Comparison
Indivior PLC
NASDAQ
Loading...
Elanco Animal Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Indivior PLC wins in 10 metrics, Elanco Animal Health wins in 8 metrics, with 0 ties. Indivior PLC appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Indivior PLC | Elanco Animal Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.99 | 19.91 | Elanco Animal Health |
| Price-to-Book Ratio | N/A | 1.28 | N/A |
| Debt-to-Equity Ratio | -1.42 | 62.13 | Indivior PLC |
| PEG Ratio | 21.94 | -0.17 | Elanco Animal Health |
| EV/EBITDA | 8.29 | 14.70 | Indivior PLC |
| Profit Margin (TTM) | 4.52% | 9.68% | Elanco Animal Health |
| Operating Margin (TTM) | 23.51% | 6.85% | Indivior PLC |
| EBITDA Margin (TTM) | 23.51% | 6.85% | Indivior PLC |
| Return on Equity | -0.57% | 6.83% | Elanco Animal Health |
| Return on Assets (TTM) | 13.14% | 0.98% | Indivior PLC |
| Free Cash Flow (TTM) | $5.00M | $380.00M | Elanco Animal Health |
| 1-Year Return | 95.53% | 22.92% | Indivior PLC |
| Price-to-Sales Ratio (TTM) | 2.50 | 1.94 | Elanco Animal Health |
| Enterprise Value | $2.79B | $12.37B | Elanco Animal Health |
| EV/Revenue Ratio | 2.38 | 2.76 | Indivior PLC |
| Gross Profit Margin (TTM) | 82.78% | 57.45% | Indivior PLC |
| Revenue per Share (TTM) | $9 | $9 | Indivior PLC |
| Earnings per Share (Diluted) | $0.81 | $0.88 | Elanco Animal Health |
| Beta (Stock Volatility) | 0.96 | 1.66 | Indivior PLC |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Indivior PLC vs Elanco Animal Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Indivior PLC | 1.12% | 3.80% | 54.17% | 113.02% | 184.62% | 92.40% |
| Elanco Animal Health | 2.40% | -0.28% | 19.96% | 41.36% | 61.21% | 48.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Indivior PLC | 95.53% | 550.00% | 1,471.90% | 617.91% | 964.16% | 964.16% |
| Elanco Animal Health | 22.92% | 16.45% | -38.52% | -47.48% | -47.48% | -47.48% |
Performance & Financial Health Analysis: Indivior PLC vs Elanco Animal Health
| Metric | INDV | ELAN |
|---|---|---|
| Market Information | ||
| Market Cap | $2.93B | $8.70B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,382,039 | 7,448,390 |
| 90 Day Avg. Volume | 3,518,626 | 5,607,183 |
| Last Close | $24.32 | $17.91 |
| 52 Week Range | $7.33 - $24.64 | $8.02 - $18.09 |
| % from 52W High | -1.30% | -1.00% |
| All-Time High | $26.50 (Jun 12, 2023) | $37.61 (Sep 24, 2018) |
| % from All-Time High | -8.23% | -52.38% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.05% |
| Quarterly Earnings Growth | 0.01% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.10% |
| Operating Margin (TTM) | 0.24% | 0.07% |
| Return on Equity (TTM) | -0.01% | 0.07% |
| Debt to Equity (MRQ) | -1.42 | 62.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.06 | $13.64 |
| Cash per Share (MRQ) | $4.09 | $1.09 |
| Operating Cash Flow (TTM) | $205.00M | $572.00M |
| Levered Free Cash Flow (TTM) | $255.25M | $1.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Indivior PLC vs Elanco Animal Health
| Metric | INDV | ELAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.99 | 19.91 |
| Forward P/E | 21.94 | 18.64 |
| PEG Ratio | 21.94 | -0.17 |
| Price to Sales (TTM) | 2.50 | 1.94 |
| Price to Book (MRQ) | N/A | 1.28 |
| Market Capitalization | ||
| Market Capitalization | $2.93B | $8.70B |
| Enterprise Value | $2.79B | $12.37B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.38 | 2.76 |
| Enterprise to EBITDA | 8.29 | 14.70 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.66 |
| Book Value per Share (MRQ) | $-2.06 | $13.64 |
Financial Statements Comparison: Indivior PLC vs Elanco Animal Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDV | ELAN |
|---|---|---|
| Revenue/Sales | $302.00M | $1.19B |
| Cost of Goods Sold | $52.00M | $509.00M |
| Gross Profit | $250.00M | $684.00M |
| Research & Development | $21.00M | $94.00M |
| Operating Income (EBIT) | $71.00M | $121.00M |
| EBITDA | $82.00M | $270.00M |
| Pre-Tax Income | $62.00M | $60.00M |
| Income Tax | $44.00M | $-7.00M |
| Net Income (Profit) | $18.00M | $67.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDV | ELAN |
|---|---|---|
| Cash & Equivalents | $372.00M | $487.00M |
| Total Current Assets | $883.00M | $3.44B |
| Total Current Liabilities | $1.01B | $1.27B |
| Long-Term Debt | $341.00M | $4.35B |
| Total Shareholders Equity | $-286.00M | $6.35B |
| Retained Earnings | $-406.00M | $-1.88B |
| Property, Plant & Equipment | $141.00M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDV | ELAN |
|---|---|---|
| Operating Cash Flow | $72.00M | $-4.00M |
| Capital Expenditures | $-5.00M | $-65.00M |
| Free Cash Flow | $70.00M | $-69.00M |
| Debt Repayment | $-4.00M | $-178.00M |
| Common Stock Repurchase | $-11.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDV | ELAN |
|---|---|---|
| Shares Short | 7.12M | 23.96M |
| Short Ratio | 2.08 | 5.44 |
| Short % of Float | 0.06% | 0.07% |
| Average Daily Volume (10 Day) | 2,382,039 | 7,448,390 |
| Average Daily Volume (90 Day) | 3,518,626 | 5,607,183 |
| Shares Outstanding | 124.90M | 494.45M |
| Float Shares | 89.80M | 492.94M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 0.95% | 1.10% |
Dividend Analysis & Yield Comparison: Indivior PLC vs Elanco Animal Health
| Metric | INDV | ELAN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |